Ozempic, Zepbound: Could They Extend Your Lifespan?

New research is exploring whether popular weight loss drugs, such as Ozempic and Zepbound, could offer benefits beyond their primary uses, potentially slowing the aging process. Early findings, including a study on semaglutide in HIV patients, indicate a possible reduction in biological aging markers. Scientists are investigating if these GLP-1 medications, known for improving metabolic health and lowering the risk of diseases like heart disease, might also influence aging pathways by reducing inflammation.

Despite this emerging promise, experts emphasize that substantial evidence proving these drugs extend lifespan in otherwise healthy individuals is still lacking. Significant concerns persist regarding potential side effects that could impact aging, such as muscle loss and decreased bone density, which may increase frailty later in life. While several clinical trials are ongoing to further assess the effects on aging, strength, and mobility, definitive results are expected to be years away. For now, medical professionals do not recommend using these medications off-label solely for longevity purposes due to insufficient supporting data.